Posted on 27-12-16
Bangalore, May 22, 2013: Curegarden, a subsidiary of Arjuna Natural Extracts Ltd (ANEL), India’s leading exporter of high grade botanical extracts, announced the arrival of their products in Bangalore. The company unveiled their revolutionary, patented ingredient BCM-95™, a 100 percent standardized extract of curcumin, the most active compound of turmeric.
The launch event announced the arrival of three Curegarden products — Natural Joint Rescue, Natural Diabetes Defense and Natural Daily Defense.
Speaking on the occasion, Mr. P.J. Kunjachan, Chairman and MD, Arjuna Natural, said, “BCM- 95™ is a revolutionary solution for inflammatory diseases. With Curegarden products now in Bangalore, we will be reaching out to our customers directly."
Dr. Benny Antony, Director Technical, Arjuna Natural, said, “With proven scientific expertise and technology, Curegarden is all set to explore the wonders of one of the most powerful botanical extracts in the world. We are pleased with the six US patents and a patent from Japan that BCM-95™ has received; the European patent is pending. We look forward to expansion to Mumbai and Chennai markets within the year.”
Curegarden products are available in 35 outlets (that includes organic product selling outlets as well as pharmaceutical stores).
Curegarden represents a dream. A dream of sharing a happier, healthier body and quality of life with the use of nature's best ingredients. Botanics, when extracted for their bioactive compounds, offer a most effective approach to improving well-being and quality of life. It is based on the belief that botanicals of the highest quality would have a positive effect — without any negative side effects — on people's health. Over the years,we have seen and experienced personally the wonderful benefits of these high quality botanical products and are delighted to share them with others.
Arjuna Natural Extracts Ltd is India’s leading manufacturer and exporter of standardized botanical extracts for pharmaceutical and nutraceutical industries for over two decades. With customers in around 40 countries, the company has close to 50 patents to its credit of which majority are commercialized globally. The company has R&D tie ups with international universities from Australia, US and Japan. The highly advanced R&D unit at Arjuna is a complete research facility for phytochemistry, pharmacokinetics, formulation and development, pre-clinical and clinical studies.
FIND US ON FACEBOOK